Barclays analyst Tom O’Malley maintains Coherent (NASDAQ:COHR) with a Underweight and raises the price target from $30 to $36.
Expert Ratings For Tenet Healthcare
Within the last quarter, Tenet Healthcare (NYSE:THC) has observed the following analyst ratings: